Cargando…

Re: ‘Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis’ by Tleyjeh et al.

Detalles Bibliográficos
Autores principales:	Koeckerling, David, Pan, Daniel, Barker, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862016/ https://www.ncbi.nlm.nih.gov/pubmed/33549765 http://dx.doi.org/10.1016/j.cmi.2021.01.025

Ejemplares similares

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
por: Kashour, Tarek, et al.
Publicado: (2021)

Response to “Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician” by Tleyjeh et al.
por: Wolkewitz, Martin, et al.
Publicado: (2021)

Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al.
por: Zeng, Guangting, et al.
Publicado: (2023)

Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis
por: Luo, Lili, et al.
Publicado: (2022)

Re: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al.
por: Mori, Nobuaki
Publicado: (2022)

Re: ‘ESCMID COVID-19 living guidelines: drug treatment and clinical management’ by Bartoletti et al
por: Dauby, Nicolas
Publicado: (2022)

Letter to the Editor re: Biglari et al. (2016)
por: Zura, Robert, et al.
Publicado: (2016)

Re: Hormonal therapies and venous thrombosis: The estrogen matters! Morimont et al.
por: LaVasseur, Corinne, et al.
Publicado: (2023)

To PPE or not to PPE? Making sense of conflicting international recommendations for PPE during chest compressions in patients with COVID-19
por: Mudalige, N. Lakmal, et al.
Publicado: (2020)

Re: Remdesivir for the treatment of COVID-19 by Lee et al.
por: Beccacece, Alessia, et al.
Publicado: (2023)

Kaya et al. Is it a typical crosstalk: Need for re-implantation?
por: Akbarzadeh, Mohammad Ali
Publicado: (2015)

Re: ‘Post-COVID-19 chronic symptoms’ by Davido et al.
por: Miglis, Mitchell G., et al.
Publicado: (2021)

RE: “Efficacy of oral contrast agents for upper gastrointestinal signal suppression in MRCP: A systematic review of the literature” by Frisch et al.
por: Rajadurai, Suraindra, et al.
Publicado: (2018)

Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.
por: Vedrines, Nicolas, et al.
Publicado: (2021)

Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM
por: Klopfenstein, Timothée, et al.
Publicado: (2022)

Mortality in COVID-19 patients treated with ACEIs/ARBs: Re-estimated meta-analysis results following the Mehra et al. retraction
por: Alamer, Ahmad, et al.
Publicado: (2020)

Re: Latex Content in Adult Vaccines, J. Davenport et al., December 10, 2019
por: Hamilton, Gavin
Publicado: (2020)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Lacout, Alexis, et al.
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Re: Accelerating clinical trial implementation in the context of the COVID-19 pandemic by Diallo et al
por: Rys, Andrzej, et al.
Publicado: (2022)

Re: ‘clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection’ by Mailhe et al.
por: Kherabi, Yousra, et al.
Publicado: (2023)

Re: ‘the unique COVID-19 presentation of patients with B cell depletion’ by Belkin et al.
por: Múñez-Rubio, Elena, et al.
Publicado: (2023)

Re: Response to In regard to Ding et al. 2020: “Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy Related Cognitive Impairment in Breast Cancer Survivors”
por: Cheng, Huaidong, et al.
Publicado: (2023)

Rebuttal to Peel et al. Re: ‘The imperative to develop a human vaccine for the Hendra virus in Australia’
por: Zahoor, Bilal
Publicado: (2016)

Letter to the editor re: Paratesticular sarcomas: a case series and literature review: Keenan et al
por: Floyd, Michael S., et al.
Publicado: (2019)

Re: ‘Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness’ by Wolkewitz et al.
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2021)

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2021)

Re: ‘Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review’ by Serafim et al.
por: Lipes, Jed, et al.
Publicado: (2021)

Re: Abrantes et al. ‘evidence-based radiography: A new methodology or the systematisation of an old practice?’ and Michele et al. ‘knowledge translation: Radiographers compared to other healthcare professionals’
por: Wolstenhulme, S.
Publicado: (2020)

Comment on “Pain in people living with HIV/AIDS: a systematic review (Parker et al. 2014)”
por: Harding, Richard, et al.
Publicado: (2014)

Response to letters by Baethge et al. and Martino et al.
por: Marwaha, Steven, et al.
Publicado: (2017)

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?
por: Kow, C.S., et al.
Publicado: (2021)

Re: 'Personal protective equipment protecting healthcare workers in the Chinese epicenter of COVID-19' by Zhao et al.
por: Wee, Liang En, et al.
Publicado: (2020)

Re: “High prevalence of heterotopic ossification in critically ill patients with severe COVID-19” by Stoira et al.
por: de l’Escalopier, Nicolas, et al.
Publicado: (2021)

Authors’ response: Re: Reifferscheid et al., “COVID-19 vaccine uptake and intention during pregnancy in Canada”
por: MacDonald, Shannon E., et al.
Publicado: (2022)

Response to Morita et al., Re: Continuous Deep Sedation (DOI: 10.1089/pmr.2021.0058)
por: Broeckaert, Bert
Publicado: (2022)

Re: Camille Girard, Mehdi Al-Akri, Matthieu Durand, et al. Efficacy, Safety, and Reoperation-free Survival of Artificial Urinary Sphincter in Non-neurological Male Patients over 75 Years of Age. Eur Urol Open Sci 2023;53:23–30
por: Perrin, Andry, et al.
Publicado: (2023)

Response to comment on “Pain in people living with HIV/AIDS: a systematic review (Parker et al. 2014)”
por: Parker, Romy, et al.
Publicado: (2014)

Re: 'Syndromic panels or “panel syndrome”? A perspective through the lens of respiratory-tract infections' by Zanella et al
por: Brendish, N.J., et al.
Publicado: (2020)

Authors’ Reply to: VanderWeele et al., Chiolero, and Schooling et al.
por: Broadbent, Alex, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8e7j1moh41u7nglndahoa6scgc